Severe imported falciparum malaria – Clinical and drug supply challenges

We read with interest a case series on a cohort of Italian patients with severe Plasmodium falciparum malaria treated in the intensive care unit with predominantly positive outcomes [1]. In light of lengthy processes of approval from the Food and Drug Administration (FDA) for drugs which are already routinely prescribed around the world, it has come to our attention that patients may not be receiving potentially life-saving antimalarial agents quickly enough to prevent rapid dissemination of parasite burden and eventual progression of disease.

Source: Travel Medicine and Infectious Disease - July 16, 2018 Category: Infectious Diseases Authors: Albert Anastasio, James Malcolm, Tommy T. Thomas, Tushar Patil Source Type: research